INS and Insulin resistance: In clinical practice, an atypical response to GDM treatment, e.g. no/little response to diet or metformin treatment, but strong response to insulin treatment indicates low insulin resistance, and is suggestive of insulin deficiency, thus justifying autoantibody testing.